FP7H2020HORIZON
The European Medicines Agency
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 15
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 1,921,546
- Active
- 2009 to 2025
Projects
15 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| RealiseDComprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases | HORIZON | 2025 | Participant | EUR 554,459 |
| EUPAHWEuropean Partnership Animal health and Welfare | HORIZON | 2024 | Associated partner | EUR 0 |
| M6ATCELLExploiting fundamental insights of m6A methylation on CD8 T cell differentiation and function to boost medicinal T cell products | HORIZON | 2023 | Associated partner | EUR 0 |
| SISAQOL-IMIEstablishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials | H2020 | 2021 | Participant | EUR 78,756 |
| PREMIERPrioritisation and Risk Evaluation of Medicines in the EnviRonment | H2020 | 2020 | Participant | EUR 47,000 |
| STARSStrengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) | H2020 | 2019 | Participant | EUR 7,500 |
| ConcePTIONBuilding an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation | H2020 | 2019 | Participant | EUR 33,158 |
| ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890 | H2020 | 2015 | Participant | EUR 0 |
| FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection | FP7 | 2015 | Participant | EUR 40,002 |
| WEB-RADRRecognising Adverse Drug Reactions | FP7 | 2014 | Participant | EUR 246,878 |
| GETREALIncorporating real-life clinical data into drug development | FP7 | 2013 | Participant | EUR 117,501 |
| ADVANCEAccelerated Development of Vaccine benefit-risk Collaboration in Europe | FP7 | 2013 | Participant | EUR 219,246 |
| GRIPGlobal Research in Paediatrics | FP7 | 2011 | Participant | EUR 150,900 |
| EU2PEuropean programme in Pharmacovigilance and Pharmacoepidemiology | FP7 | 2009 | Participant | EUR 29,889 |
| PROTECTPharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium | FP7 | 2009 | Coordinator | EUR 396,258 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.